Ivy Life Sciences, Co., Ltd
3 clinical trials · Sponsor
◉ Watch Ivy Life Sciences, Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy (NCT03499834) | Ivy Life Sciences, Co., Ltd | 2017-12-05 |
| Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy (NCT03592706) | Ivy Life Sciences, Co., Ltd | 2009-12-01 |
| Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer (NCT03515252) | Ivy Life Sciences, Co., Ltd | 2005-04-26 |
Track Ivy Life Sciences, Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.